Table 1.
The comparison of CBD to phenytoin and carbamazepine
Parameter | Cannabidiol | Phenytoin | Carbamazepine |
---|---|---|---|
Brain–lipid binding–TRANSIL (%) | 99.6 | 98.5 | 83.7 |
Plasma–protein binding (%) | ∼95–99a | 95a | ∼70a |
IC50 on Nav channels (μm) | 1–4 | ∼10a | ∼25a |
ED50 MES (mg/kg) | ∼120a | 8.2–17.5a | 7.5a |
Efficacious plasma level (μm) | 6.4–8.3a | 4–10a | 5–12a |
Brain concentration (μm) | 21.9a | 86a | 9.7a |
Brain/IC50 (ratio) | 5.5–21.9 | 8.6 | 0.4 |